Pediatric super-refractory status epilepticus treated with allopregnanolone

Eileen Broomall1, JoAnne E Natale, Michele Grimason

  • 1Ruth D. and Ken M. Davee Pediatric Neurocritical Care Program, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL.

Annals of Neurology
|November 4, 2014
PubMed

Insights

Super-refractory status epilepticus (SRSE) is a severe condition. Allopregnanolone successfully treated SRSE in two pediatric patients, resolving seizures and allowing anesthetic weaning.

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Pharmacology

Background:

  • Super-refractory status epilepticus (SRSE) is a critical neurological emergency.
  • Treatment resistance in SRSE is linked to synaptic GABAA receptor internalization.
  • GABAA receptor dysfunction contributes to persistent seizures.

Observation:

  • Two pediatric patients with SRSE were treated with the neurosteroid allopregnanolone.
  • Allopregnanolone modulates GABAA receptors, acting as a positive allosteric modulator.
  • This neurosteroid targets both synaptic and extrasynaptic GABAA receptors.

Findings:

  • Allopregnanolone administration led to the resolution of status epilepticus in both pediatric cases.
  • Patients were able to be weaned off general anesthetic infusions following treatment.
  • This represents the first documented use of allopregnanolone for pediatric SRSE.

Implications:

  • Allopregnanolone shows promise as a novel therapeutic agent for refractory epilepsy syndromes.
  • Targeting GABAA receptors with neurosteroids may offer a new strategy for managing severe seizures.
  • Further research is warranted to explore allopregnanolone's efficacy and safety in pediatric epilepsy.

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
982
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
785